Abstract:Neovascular diseases of the fundus are a group of disorders caused by pathological abnormal proliferation of blood vessels in the choroid and retina, which induces a series of clinical pathological changes and represents one of the major causes of fundus tissue damage and severe visual impairment. In recent years, immune-inflammatory responses have been confirmed as a key driver of neovascularization. As a T cell subset with negative immune regulatory functions and a core regulator for maintaining immune homeostasis, regulatory T cells(Tregs)play an increasingly prominent role in the initiation and progression of fundus neovascularization and have become a research hotspot in this field. This review systematically summarizes the core mechanisms by which Tregs mediate angiogenesis via modulation of the ocular immune microenvironment, illustrates their context-dependent dual effects under different disease conditions and at various disease stages, and outlines cutting-edge Treg-targeted therapeutic strategies. It aims to provide forward-looking references for mechanistic research and translational clinical diagnosis and treatment of such diseases.